Douglas Rhee, MD
Show Description +
Douglas Rhee, MD, discusses new drugs in the pipeline that may soon be available to patients. These new offerings may help ophthalmologists shift from a palliative approach to glaucoma and move toward treatment that interrupts the primary physiology of the disease.
Posted: 3/01/2017
Douglas Rhee, MD
Douglas Rhee, MD, discusses new drugs in the pipeline that may soon be available to patients. These new offerings may help ophthalmologists shift from a palliative approach to glaucoma and move toward treatment that interrupts the primary physiology of the disease.
Posted: 3/01/2017
Bryn Mawr Communications, LLC, and Eyetube.net are not affiliated with the official program of AGS: 2017.
Please log in to leave a comment.